GRB Medical Limited 08896593 false 2024-03-01 2025-02-28 2025-02-28 The principal activity of the company is Sales Agent For Medical Products Digita Accounts Production Advanced 6.30.9574.0 true 08896593 2024-03-01 2025-02-28 08896593 2025-02-28 08896593 core:CurrentFinancialInstruments core:WithinOneYear 2025-02-28 08896593 bus:Micro-entities 2024-03-01 2025-02-28 08896593 bus:AuditExemptWithAccountantsReport 2024-03-01 2025-02-28 08896593 bus:FilletedAccounts 2024-03-01 2025-02-28 08896593 bus:SmallCompaniesRegimeForAccounts 2024-03-01 2025-02-28 08896593 bus:RegisteredOffice 2024-03-01 2025-02-28 08896593 bus:Director1 2024-03-01 2025-02-28 08896593 bus:PrivateLimitedCompanyLtd 2024-03-01 2025-02-28 08896593 countries:England 2024-03-01 2025-02-28 08896593 2023-03-01 2024-02-29 08896593 2024-02-29 08896593 core:CurrentFinancialInstruments core:WithinOneYear 2024-02-29 iso4217:GBP xbrli:pure

Registration number: 08896593

GRB Medical Limited

Unaudited Filleted Accounts

for the Year Ended 28 February 2025

 

GRB Medical Limited

(Registration number: 08896593)

Balance Sheet

28 February 2025

2025
£

2024
£

Fixed assets

311,823

229,226

Current assets

90,359

68,214

Prepayments and accrued income

233

233

Creditors: Amounts falling due within one year

(72,288)

(62,559)

Net current assets

18,304

5,888

Total assets less current liabilities

330,127

235,114

Accruals and deferred income

(4,950)

(3,922)

 

325,177

231,192

Capital and reserves

325,177

231,192

 

GRB Medical Limited

(Registration number: 08896593)

Balance Sheet

28 February 2025

1

General information

The company is a private company limited by share capital, incorporated in England.

The address of its registered office is:
20 Kirkgate
Sherburn in Elmet
Leeds
North Yorkshire
LS25 6BL

These financial statements were authorised for issue by the Board on 28 March 2025.

Basis of preparation

The financial statements have been prepared under the historical cost convention and in accordance with FRS 105 'The Financial Reporting Standard applicable to the Micro-entities Regime'.

2

Staff numbers

The average number of persons employed by the company (including directors) during the year, was 2 (2024 - 2).

For the financial year ending 28 February 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the micro-entity provisions of the Companies Act 2006 and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the directors have not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the Board on 28 March 2025 and signed on its behalf by:.
 

.........................................

G.R. Baker
Director